Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Gap Analysis
100%
Alphavirus
100%
Eastern Equine Encephalitis Virus
100%
Antiviral Drug Development
100%
Venezuelan Equine Encephalitis Virus
50%
Virus
33%
Medical Treatment
16%
Drug Development
16%
Successful Development
16%
Human Health
16%
Pharmaceutical Intervention
16%
FDA-approved Drugs
16%
Chemical Defense
16%
Antiviral Drugs
16%
Natural Infection
16%
Non-structural Protein
16%
Biological Weapons
16%
Threat Reduction
16%
Antiviral Drug Discovery
16%
Viral Encephalitis
16%
Target Discovery
16%
Antiviral Vaccines
16%
Viral Risk
16%
Etiological Agent
16%
Threat Agents
16%
Funding Research
16%
Biological Defense
16%
DTRA
16%
Drug Discovery Program
16%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Development
100%
Antivirus Agent
100%
Alphavirus
100%
Western Equine Encephalitis Virus
100%
Venezuelan Equine Encephalitis Virus
100%
Eastern Equine Encephalitis Virus
100%
Drug Discovery
66%
Infection
66%
Virus
66%
Virus Vaccine
33%
Virus Encephalitis
33%
Immunology and Microbiology
Alphavirus
100%
Eastern Equine Encephalitis Virus
100%
Venezuelan Equine Encephalitis Virus
100%
Western Equine Encephalitis Virus
100%
Infectious Disease
66%
Virus
66%
Infection
66%
Viral Encephalitis
33%
Veterinary Science and Veterinary Medicine
Venezuelan Equine Encephalitis Virus
100%
Antivirus Agent
100%
Eastern Equine Encephalitis Virus
100%
Western Equine Encephalitis Virus
100%
Infectious Disease
66%
Viral Encephalitis
33%
Public Health
33%